Niels Hansen | Psychiatry | Best Paper Award

Dr. Niels Hansen | Psychiatry | Best Paper Award  🏆

Senior physician at University Medical Center Göttingen, Germany

Dr. Niels Hansen is a distinguished clinical neuroscientist, neurologist, psychiatrist, and psychotherapist, leading the “Translational Psychoneuroscience” research group. He oversees the biomaterial bank and EEG laboratory in the Department of Psychiatry and Psychotherapy. His research focuses on dementia, biological psychiatry, and autoantibodies, with groundbreaking projects on Alzheimer’s, Lewy body dementia, and psychiatric disorders. A prolific editor and collaborator, Dr. Hansen works with leading networks like the European Alzheimer’s Disease Consortium and German Dementia Registry. His expertise bridges clinical application and innovative research, aiming to unravel the immune and biological underpinnings of neurological and psychiatric diseases.

Profile

Scopus

Google Scholar

Orcid

Education 🎓:

Dr. Niels Hansen possesses a robust educational background in clinical neuroscience and psychiatry, underpinning his expertise as a neurologist, psychiatrist, and psychotherapist. He has undergone extensive training in translational psychoneuroscience, equipping him with advanced knowledge in the fields of dementia, neurodegenerative disorders, and psychiatric diseases. His academic journey reflects a commitment to bridging the gap between basic research and clinical application, fostering innovative approaches to understanding and treating complex neurological and psychiatric conditions. Dr. Hansen’s education has laid the foundation for his significant contributions to the scientific community and his leadership in pioneering research projects.

Work Experience 💼:

Dr. Niels Hansen has extensive professional experience spanning clinical practice, research, and leadership in neuroscience and psychiatry. He currently leads the “Translational Psychoneuroscience” research group, where he combines clinical expertise with innovative research methodologies. Dr. Hansen manages the biomaterial bank and EEG laboratory within the Department of Psychiatry and Psychotherapy, advancing diagnostic and therapeutic approaches. His collaborations with prominent organizations such as the European Alzheimer’s Disease Consortium and the German Dementia Registry highlight his commitment to interdisciplinary and translational research. With a focus on dementia, biological psychiatry, and the role of autoantibodies, Dr. Hansen’s career exemplifies a dedication to addressing complex neurological and psychiatric disorders.

Awards and Honors

Dr. Niels Hansen has received numerous awards and honors throughout his career, reflecting his outstanding contributions to neuroscience and psychiatry. His innovative research and clinical excellence have earned him recognition from esteemed scientific organizations. Notably, he has been honored for his work on dementia and the role of autoantibodies in psychiatric disorders, highlighting the translational impact of his studies. These accolades underscore his dedication to advancing the field of biological psychiatry and his efforts to bridge the gap between research and clinical application.

Research Interests:

Dr. Niels Hansen’s research interests lie at the intersection of neuroscience, psychiatry, and translational medicine. His work primarily focuses on dementia, with an emphasis on understanding its neurobiological underpinnings and exploring innovative therapeutic strategies. He investigates the role of autoantibodies in psychiatric and neurological disorders, bridging the gap between immunology and mental health. Additionally, Dr. Hansen explores biological psychiatry, employing advanced neuroimaging and EEG techniques to uncover biomarkers for early diagnosis and personalized treatment. His commitment to translational research ensures that his findings have direct clinical implications, driving progress in the diagnosis and management of complex brain disorders.

📚 Publication 

Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: A population-based study

  • Authors: D. Mueller, M. Obermann, M.S. Yoon, F. Poitz, N. Hansen, M.A. Slomke, et al.
  • Journal: Cephalalgia
  • Volume: 31
  • Issue: 15
  • Pages: 1542–1548
  • Year: 2011
  • Cited By: 326

International consensus based review and recommendations for minimum reporting standards in research on transcutaneous vagus nerve stimulation (version 2020)

  • Authors: A. Farmer, Adam, Strzelczyk, A. Finisguerra, A.V. Gourine, G. Alireza, et al.
  • Year: 2021
  • Cited By: 258

Dopamine D1/D5 receptors mediate informational saliency that promotes persistent hippocampal long-term plasticity

  • Authors: N. Hansen, D. Manahan-Vaughan
  • Journal: Cerebral Cortex
  • Volume: 24
  • Issue: 4
  • Pages: 845–858
  • Year: 2014
  • Cited By: 207

β-adrenergic control of hippocampal function: Subserving the choreography of synaptic information storage and memory

  • Authors: H. Hagena, N. Hansen, D. Manahan-Vaughan
  • Journal: Cerebral Cortex
  • Volume: 26
  • Issue: 4
  • Pages: 1349–1364
  • Year: 2016
  • Cited By: 169

The longevity of hippocampus‐dependent memory is orchestrated by the locus coeruleus‐noradrenergic system

  • Authors: N. Hansen
  • Journal: Neural Plasticity
  • Volume: 2017
  • Article Number: 2727602
  • Year: 2017
  • Cited By: 112

Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: Real-world evidence from the GENERATE registry

  • Authors: F.S. Thaler, L. Zimmermann, S. Kammermeier, C. Strippel, M. Ringelstein, et al.
  • Journal: Neurology: Neuroimmunology & Neuroinflammation
  • Volume: 8
  • Issue: 6
  • Article Number: e1088
  • Year: 2021
  • Cited By: 104

Locus coeruleus stimulation facilitates long-term depression in the dentate gyrus that requires activation of β-adrenergic receptors

  • Authors: N. Hansen, D. Manahan-Vaughan
  • Journal: Cerebral Cortex
  • Volume: 25
  • Issue: 7
  • Pages: 1889–1896
  • Year: 2015
  • Cited By: 97

Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach

  • Authors: N. Hansen, M. Lipp, J. Vogelgsang, R. Vukovich, T. Zindler, D. Luedecke, et al.
  • Journal: Brain, Behavior, & Immunity-Health
  • Volume: 9
  • Article Number: 100154
  • Year: 2020
  • Cited By: 41

Conclusion 

Dr. Hansen’s outstanding research contributions, leadership in high-impact projects, and dedication to advancing neuroscience make him a compelling candidate for the Research for Best Paper Award. His work aligns perfectly with the award’s objective of recognizing groundbreaking advancements in the field.

 

Xinhong Zhu | Psychiatric Disorders | Best Researcher Award

Prof. Xinhong Zhu | Psychiatric Disorders | Best Researcher Award 🏆

Director at Pazhou Lab, China

Prof. Xinhong Zhu is an accomplished neuroscientist and expert in integrative medicine, with a career dedicated to advancing brain health and mental health research. He earned his M.D. from Henan Traditional Chinese Medical College (1991), followed by an M.S. in Chinese Integrative Medicine (2002) and a Ph.D. in Neuroscience (2005) from The First Military Medical University, China. Currently, he serves as a Professor at the School of Biology and Biological Engineering, South China University of Technology, and as Distinguished Professor and Director of the Research Center for Brain Health, Pazhou Lab. With over 30 years of professional experience, Prof. Zhu has held leadership roles at Southern Medical University and contributed to groundbreaking studies on antidepressant mechanisms, neuroprotection, and psychological resilience. His achievements have been recognized with prestigious awards, including the National Outstanding Youth Fund and multiple Guangdong Provincial Science and Technology Progress Awards. A prolific researcher and educator, Prof. Zhu is a member of leading neuroscience societies and continues to make significant contributions to the field through his impactful publications and innovative research.

Profile

Scopus

Education 🎓:

Prof. Xinhong Zhu’s academic journey is marked by exceptional accomplishments in medicine and neuroscience. He earned his M.D. from Henan Traditional Chinese Medical College, China, in 1991, laying a strong foundation in traditional Chinese medicine. He advanced his expertise with an M.S. in Chinese Integrative Medicine from The First Military Medical University in 2002, where he also completed his Ph.D. in Neuroscience in 2005. His global perspective was further enriched during his tenure as a visiting scientist at the IMMAG, Medical College of Georgia, USA, from January 2009 to August 2010, where he expanded his research capabilities in advanced neuroscience. This diverse and comprehensive education has equipped him to make pioneering contributions in medicine and neurobiology.

Work Experience 💼:

Prof. Xinhong Zhu has a distinguished career spanning clinical practice and academic leadership in neuroscience and integrative medicine. He is currently a Professor at South China University of Technology and Director of the Research Center for Brain Health at Pazhou Lab. Previously, he served as Executive Director of the Institute of Mental Health and Professor of Neurobiology at Southern Medical University. With roles ranging from clinician to educator and researcher, Prof. Zhu has significantly advanced neuroscience and brain health research.

Skills 🔍

Prof. Xinhong Zhu possesses exceptional skills in neuroscience research, particularly in studying neurobiological mechanisms and therapeutic strategies for mental health disorders. His expertise includes integrative medicine, with a strong foundation in traditional Chinese medical practices combined with modern biomedical approaches. He excels in advanced neurophysiology techniques, molecular biology, and pharmacological investigations. Additionally, Prof. Zhu has proven leadership and project management skills, directing multidisciplinary research centers and collaborative teams. His capabilities extend to teaching, mentoring, and publishing impactful scientific work, showcasing his ability to translate complex scientific concepts into practical applications.

Awards and Honors 🏆

Prof. Xinhong Zhu has received numerous prestigious awards and honors throughout his career, reflecting his significant contributions to neuroscience and integrative medicine. He was a recipient of the National Outstanding Youth Fund (2013) and was recognized among the Leading Talents in the Ten Thousand Talents Plan (2017). Prof. Zhu was honored as one of the Young and Middle-Aged Experts with Outstanding Contributions to National Health (2019). His groundbreaking research earned him the Second Prize in National Natural Science (2019) for work on new mechanisms and targets for antidepressants. He also secured the First Prize of Guangdong Provincial Science and Technology Progress Award twice, for his research on neuroprotective targets for ischemic stroke (2010) and novel antidepressant targets and methods (2016). These accolades underscore his influential role in advancing brain health and therapeutic innovations.

Research Interests:

Prof. Xinhong Zhu’s research interests lie at the intersection of neuroscience, integrative medicine, and brain health. He focuses on uncovering new mechanisms and therapeutic targets for neuropsychiatric disorders, including depression, anxiety, and autism. His work also explores neuroprotective strategies for ischemic stroke and innovative methods for antidepressant development. Prof. Zhu’s interdisciplinary approach bridges traditional Chinese medicine and modern neuroscience, aiming to enhance psychological resilience and neurobiological understanding through cutting-edge research.

📚 Publications 

  • Title: Discovery of Glycosidated Glycyrrhetinic Acid Derivatives: Natural Product-Based Soluble Epoxide Hydrolase Inhibitors
    • Authors: Q. Liu, Y.-X. Wang, Z.-H. Ge, X.-H. Zhu, J.-H. Liang
    • Journal: European Journal of Medicinal Chemistry
    • Year: 2024
    • Volume/Issue: 280, 116937
    • Citations: 0
  • Title: Discovery of Orally Active Phenylquinoline-Based Soluble Epoxide Hydrolase Inhibitors with Anti-Inflammatory and Analgesic Activity
    • Authors: J. Ding, M.-Z. Zhu, S.-M. Liu, X.-H. Zhu, J.-H. Liang
    • Journal: Journal of Medicinal Chemistry
    • Year: 2024
    • Volume/Issue: 67(20), 18412–18447
    • Citations: 0
  • Title: Discovery of a Novel Lead Characterized by a Stilbene-Extended Scaffold Against Sepsis as Soluble Epoxide Hydrolase Inhibitors
    • Authors: Z.-Q. Feng, J. Ding, M.-Z. Zhu, X.-H. Zhu, J.-H. Liang
    • Journal: European Journal of Medicinal Chemistry
    • Year: 2024
    • Volume/Issue: 266, 116113
    • Citations: 3
  • Title: Intermittent Hypobaric Hypoxia Ameliorates Autistic-Like Phenotypes in Mice
    • Authors: Y.-D. Pan, Y. Zhang, W.-Y. Zheng, Q.-Q. Wen, X.-H. Zhu
    • Journal: Journal of Neuroscience
    • Year: 2024
    • Volume/Issue: 44(7), e1665232023
    • Citations: 0
  • Title: Enhancing HIF-1α–P2X2 Signaling in Dorsal Raphe Serotonergic Neurons Promotes Psychological Resilience
    • Authors: Y. Zhang, Y.-D. Pan, W.-Y. Zheng, N. Mechawar, X.-H. Zhu
    • Journal: Redox Biology
    • Year: 2024
    • Volume/Issue: 69, 103005
    • Citations: 1
  • Title: Hepatic Soluble Epoxide Hydrolase Activity Regulates Cerebral Aβ Metabolism and the Pathogenesis of Alzheimer’s Disease in Mice
    • Authors: Y. Wu, J.-H. Dong, Y.-F. Dai, Y.-Q. Li, X.-H. Zhu
    • Journal: Neuron
    • Year: 2023
    • Volume/Issue: 111(18), 2847–2862.e10
    • Citations: 21
  • Title: Deletion of Transferrin Receptor 1 in Parvalbumin Interneurons Induces a Hereditary Spastic Paraplegia-Like Phenotype
    • Authors: W. Xiong, L. Jin, Y. Zhao, Y. Pan, X. Zhu
    • Journal: Journal of Neuroscience
    • Year: 2023
    • Volume/Issue: 43(27), 5092–5113
    • Citations: 0
  • Title: A Thalamic-Primary Auditory Cortex Circuit Mediates Resilience to Stress
    • Authors: H.-Y. Li, M.-Z. Zhu, X.-R. Yuan, Y.-Q. Li, X.-H. Zhu
    • Journal: Cell
    • Year: 2023
    • Volume/Issue: 186(7), 1352–1368.e18
    • Citations: 19

Conclusion 

Prof. Xinhong Zhu’s extensive academic qualifications, leadership in neuroscience, impactful research, and global recognition make him a compelling candidate for the Best Researcher Award. His work exemplifies excellence, innovation, and real-world impact, aligning perfectly with the award’s objectives.